Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group. [electronic resource]
Producer: 19990714Description: 2407-15 p. digitalISSN:- 0269-9370
- AIDS Vaccines -- adverse effects
- Adolescent
- Adult
- Avipoxvirus -- immunology
- CD8-Positive T-Lymphocytes
- Double-Blind Method
- HIV Antibodies -- blood
- HIV Envelope Protein gp120 -- immunology
- HIV Infections -- prevention & control
- HIV-1 -- immunology
- Humans
- Immunization Schedule
- Middle Aged
- Neutralization Tests
- Peptide Fragments -- immunology
- Prospective Studies
- T-Lymphocytes, Cytotoxic -- immunology
- Vaccines, Synthetic
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.